SEARCH

SEARCH BY CITATION

References

  • Agopian A. and Guo Z. (2012) Structural origin of polymorphism for Alzheimer's amyloid-β fibrils. Biochem. J. 447, 4350.
  • Baker R. T., Catanzariti A. M., Karunasekara Y., Soboleva T. A., Sharwood R., Whitney S. and Board P. G. (2005) Using deubiquitylating enzymes as research tools. Methods Enzymol. 398, 540554.
  • Bertini I., Gonnelli L., Luchinat C., Mao J. and Nesi A. (2011) A new structural model of Aβ40 fibrils. J. Am. Chem. Soc., 133, 1601316022.
  • Brody D. L., Magnoni S., Schwetye K. E., Spinner M. L., Esparza T. J., Stocchetti N., Zipfel G. J. and Holtzman D. M. (2008) Amyloid-beta dynamics correlate with neurological status in the injured human brain. Science 321, 12211224.
  • Budil D. E., Lee S., Saxena S. and Freed J. H. (1996) Nonlinear-least-squares analysis of slow-motion EPR spectra in one and two dimensions using a modified Levenberg-Marquardt algorithm. J. Magn. Reson. Ser. A 120, 155189.
  • Columbus L., Kálai T., Jeko J., Hideg K. and Hubbell W. L. (2001) Molecular motion of spin labeled side chains in α-helices: analysis by variation of side chain structure. Biochemistry 40, 38283846.
  • Frost D., Gorman P. M., Yip C. M. and Chakrabartty A. (2003) Co-incorporation of Aβ40 and Aβ42 to form mixed pre-fibrillar aggregates. Eur. J. Biochem. 270, 654663.
  • Gravina S. A., Ho L. B., Eckman C. B., Long K. E., Otvos L., Younkin L. H., Suzuki N. and Younkin S. G. (1995) Amyloid β protein (Aβ) in Alzheimer's disease brain: biochemical and immunocytochemical analysis with antibodies specific for forms ending at Aβ40 or Aβ42(43). J. Biol. Chem. 270, 70137016.
  • Iwatsubo T., Odaka A., Suzuki N., Mizusawa H., Nukina N. and Ihara Y. (1994) Visualization of Aβ42(43) and Aβ40 in senile plaques with end-specific Aβ monoclonals: evidence that an initially deposited species is Aβ42(43). Neuron 13, 4553.
  • Iwatsubo T., Mann D. M. A., Odaka A., Suzuki N. and Ihara Y. (1995) Amyloid β protein (Aβ) deposition: Aβ42(43) precedes Aβ40 in Down syndrome. Ann. Neurol. 37, 294299.
  • Jan A., Gokce O., Luthi-Carter R. and Lashuel H. A. (2008) The ratio of monomeric to aggregated forms of Abeta40 and Abeta42 is an important determinant of amyloid-beta aggregation, fibrillogenesis, and toxicity. J. Biol. Chem. 283, 2817628189.
  • Kim J., Onstead L., Randle S., Price R., Smithson L., Zwizinski C., Dickson D. W., Golde T. and McGowan E. (2007) Abeta40 inhibits amyloid deposition in vivo. J. Neurosci. 27, 627633.
  • Kodali R., Williams A. D., Chemuru S. and Wetzel R. (2010) Aβ(1–40) forms five distinct amyloid structures whose β-sheet contents and fibril stabilities are correlated. J. Mol. Biol. 401, 503517.
  • Kumar-Singh S., Theuns J., Van Broeck B., Pirici D., Vennekens K., Corsmit E., Cruts M., Dermaut B., Wang R. and Van Broeckhoven C. (2006) Mean age-of-onset of familial Alzheimer disease caused by presenilin mutations correlates with both increased Aβ42 and decreased Aβ40. Hum. Mutat. 27, 686695.
  • Kuperstein I., Broersen K., Benilova I. et al. (2010) Neurotoxicity of Alzheimer's disease Abeta peptides is induced by small changes in the Aβ42 to Aβ40 ratio. EMBO J. 29, 34083420.
  • Lührs T., Ritter C., Adrian M., Riek-Loher D., Bohrmann B., Doeli H., Schubert D. and Riek R. (2005) 3D structure of Alzheimer's amyloid-β(1–42) fibrils. Proc. Natl Acad. Sci. USA 102, 1734217347.
  • Mak K., Yang F. S., Vinters H. V., Frautschy S. A. and Cole G. M. (1994) Polyclonals to beta-amyloid(1–42) identify most plaque and vascular deposits in Alzheimer cortex, but not striatum. Brain Res. 667, 138142.
  • Margittai M. and Langen R. (2008) Fibrils with parallel in-register structure constitute a major class of amyloid fibrils: molecular insights from electron paramagnetic resonance spectroscopy. Q. Rev. Biophys. 41, 265297.
  • McGowan E., Pickford F., Kim J. et al. (2005) Abeta42 is essential for parenchymal and vascular amyloid deposition in mice. Neuron 47, 191199.
  • Miller D. L., Papayannopoulos I. A., Styles J., Bobin S. A., Lin Y. Y., Biemann K. and Iqbal K. (1993) Peptide compositions of the cerebrovascular and senile plaque core amyloid deposits of Alzheimer's disease. Arch. Biochem. Biophys. 301, 4152.
  • Ngo S. and Guo Z. (2011) Key residues for the oligomerization of Aβ42 protein in Alzheimer's disease. Biochem. Biophys. Res. Commun. 414, 512516.
  • Olofsson A., Sauer-Eriksson A. E. and Ohman A. (2006) The solvent protection of Alzheimer amyloid-β-(1–42) fibrils as determined by solution NMR spectroscopy. J. Biol. Chem. 281, 477483.
  • Pauwels K., Williams T. L., Morris K. L. et al. (2012) The structural basis for increased toxicity of pathological Aβ42:Aβ40 ratios in Alzheimer's disease. J. Biol. Chem. 287, 56505660.
  • Petkova A. T., Leapman R. D., Guo Z. H., Yau W. M., Mattson M. P. and Tycko R. (2005) Self-propagating, molecular-level polymorphism in Alzheimer's β-amyloid fibrils. Science 307, 262265.
  • Schneider D. J. and Freed J. H. (1989) Calculating slow motional magnetic resonance specta, in Spin Labeling: Theory and Applications, (Berliner L. J. and Reuben J., eds), pp. 176. Plenum Press, New York.
  • Shahnawaz M., Thapa A. and Park I. S. (2007) Stable activity of a deubiquitylating enzyme (Usp2-cc) in the presence of high concentrations of urea and its application to purify aggregation-prone peptides. Biochem. Biophys. Res. Commun. 359, 801805.
  • Snyder S. W., Ladror U. S., Wade W. S., Wang G. T., Barrett L. W., Matayoshi E. D., Huffaker H. J., Krafft G. A. and Holzman T. F. (1994) Amyloid-beta aggregation: selective inhibition of aggregation in mixtures of amyloid with different chain lengths. Biophys. J. 67, 12161228.
  • Török M., Milton S., Kayed R., Wu P., McIntire T., Glabe C. G. and Langen R. (2002) Structural and dynamic features of Alzheimer's Aβ peptide in amyloid fibrils studied by site-directed spin labeling. J. Biol. Chem. 277, 4081040815.
  • Tycko R. (2006) Molecular structure of amyloid fibrils: insights from solid-state NMR. Q. Rev. Biophys. 39, 155.
  • Yan Y. and Wang C. (2007) Aβ40 protects non-toxic Aβ42 monomer from aggregation. J. Mol. Biol. 369, 909916.
  • Yoshiike Y., Chui D. H., Akagi T., Tanaka N. and Takashima A. (2003) Specific compositions of amyloid-beta peptides as the determinant of toxic beta-aggregation. J. Biol. Chem. 278, 2364823655.